Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Bone and Mineral Research

• Publication date

  1996-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jbmr.5650110802PMID 8854239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.

  1995cited by this paper
• Endogenous bone‐resorbing factors in estrogen deficiency: Cooperative effects of IL‐1 and IL‐6

  1995cited by this paper
• Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.

  1995cited by this paper
• Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids.

  1995cited by this paper
• Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

  1995cited by this paper
• Elevated Plasma Levels of Interleukin‐6 in Postmenopausal Women Do Not Correlate with Bone Density

  1995cited by this paper
• Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.

  1995cited by this paper
• Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

  1995cited by this paper
• Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

  1995cited by this paper
• Bone resorption at the femoral neck is dependent on local factors in nonosteoporotic late postmenopausal women: An in vitro‐in vivo study

  1995cited by this paper
• Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement.

  1995cited by this paper
• Knockout mouse fault lines

  1995cited by this paper
• 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism.

  1994cited by this paper
• Persistent bone-sparing effect of interleukin-1 receptor antagonist: A hypothesis on the role of IL-1 in ovariectomy-induced bone loss

  1994cited by this paper
• Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor.

  1994cited by this paper
• Circulating cytokine levels in osteoporotic and normal women.

  1994cited by this paper
• Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.

  1994cited by this paper
• Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion.

  1994cited by this paper
• The biological properties of interleukin-1.

  1994cited by this paper
• Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis

  1994cited by this paper
• Skeletal effects of estrogen.

  1994cited by this paper
• Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

  1994cited by this paper
• Cytokines and estrogen in bone: anti-osteoporotic effects.

  1993cited by this paper
• Differences in the time course of the effects of oophorectomy in women on parameters of bone metabolism and interleukin-1 levels in the circulation.

  1993cited by this paper
• Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats

  1993cited by this paper
• Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines.

  1993cited by this paper
• Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.

  1993cited by this paper
• Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal.

  1993cited by this paper
• Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy.

  1993cited by this paper
• Presence of estrogen-binding sites on macrophage-like synoviocytes and CD8+, CD29+, CD45RO+ T lymphocytes in normal and rheumatoid synovium.

  1993cited by this paper
• Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

  1993cited by this paper
• Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis

  1993cited by this paper
• Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis

  1993cited by this paper
• Spontaneous release of interleukin-I and interleukin-6 by peripheral blood mononuclear cells after oophorectomy.

  1992cited by this paper
• Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol.

  1992cited by this paper
• Modulation of osteoclast differentiation.

  1992cited by this paper
• Collagen-induced release of interleukin 1 from human blood mononuclear cells. Potentiation by fibronectin binding to the alpha 5 beta 1 integrin.

  1992cited by this paper
• Increased osteoclast development after estrogen loss: mediation by interleukin-6.

  1992cited by this paper
• Perspectives: Interleukin‐6: An osteotropic factor?

  1992cited by this paper
• Interleukin-6: an osteotropic factor?

  1992cited by this paper
• Long-Term Consequences of Interleukin-6 Overexpression in Transgenic Mice

  1992cited by this paper
• Oestradiol inhibits the release of tumour necrosis factor but not interleukin 6 from adult human osteoblasts in vitro

  1992cited by this paper
• 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.

  1992cited by this paper
• IL-1ra: properties and uses of an interleukin-1 receptor antagonist.

  1991cited by this paper
• Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.

  1991cited by this paper
• Macrophage heterogeneity occurs through a developmental mechanism.

  1991cited by this paper
• Modulation of Transforming Growth Factor-/? Production in Normal Human Osteoblast-Like Cells by 17/?-Estradiol and Parathyroid Hormone

  1991cited by this paper
• Human anti-interleukin 1α antibodies

  1991cited by this paper
• Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo.

  1991cited by this paper
• Role of colony‐stimulating factors in osteoclast development

  1991cited by this paper
• Cytokine production by peripheral blood cells in postmenopausal osteoporosis.

  1991cited by this paper
• Interleukin-1 and interleukin-1 antagonism.

  1991cited by this paper
• 1-Hydroxyethylidene-1,1-bisphosphonate decreases the postovariectomy enhanced interleukin 1 secretion from peritoneal macrophages in adult rats

  1991cited by this paper
• Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone.

  1991cited by this paper
• Modulation of Transforming Growth Factor-β Production in Normal Human Osteoblast-Like Cells by 17β-Estradiol and Parathyroid Hormone

  1991cited by this paper
• Human anti-interleukin 1 alpha antibodies.

  1991cited by this paper
• Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype

  1991cited by this paper
• Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells.

  1991cited by this paper
• A soluble binding protein specific for interleukin 1 beta is produced by activated mononuclear cells.

  1990cited by this paper
• The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

  1990cited by this paper
• Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse.

  1990cited by this paper
• Oestrogen Receptors in Macrophages

  1990cited by this paper
• IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA.

  1990cited by this paper
• Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women

  1990cited by this paper
• Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria.

  1990cited by this paper
• Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures.

  1990cited by this paper
• Spontaneous release of interleukin-1 (IL-1) from medullary mononuclear cells of pagetic subjects

  1989cited by this paper
• Interleukin‐1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro

  1989cited by this paper
• Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice.

  1989cited by this paper
• Bone-resorbing cytokines enhance release of macrophage colony-stimulating activity by the osteoblastic cell MC3T3-E1

  1989cited by this paper
• Generation of osteoclasts from isolated hematopoietic progenitor cells.

  1989cited by this paper
• Pluripotent hemopoietic stem cells give rise to osteoclasts in vitro: effects of rGM-CSF.

  1989cited by this paper
• Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.

  1989cited by this paper
• Reduced bone mass in reproductive-aged women with endometriosis.

  1989cited by this paper
• Effects of interleukin-1 on bone turnover in normal mice.

  1989cited by this paper
• Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis.

  1989cited by this paper
• Progesterone and estradiol modulate interleukin-1 beta messenger ribonucleic acid levels in cultured human peripheral monocytes.

  1989cited by this paper
• Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice.

  1988cited by this paper
• Bone disease in rheumatoid arthritis.

  1988cited by this paper
• Interleukin-1: a possible role in the infertility associated with endometriosis.

  1987cited by this paper
• Interleukin‐1β is a potent inhibitor of bone formation in vitro

  1987cited by this paper
• Interleukin-1 beta is a potent inhibitor of bone formation in vitro.

  1987cited by this paper
• Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis.

  1987cited by this paper
• Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.

  1987cited by this paper
• Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro.

  1987cited by this paper
• Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1.

  1987cited by this paper
• Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts

  1986cited by this paper
• Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae.

  1986cited by this paper
• Presence of oestrogen receptors in human blood mononuclear cells and thymocytes.

  1986cited by this paper
• Effects of human recombinant CSF‐GM and highly purified CSF‐1 on the formation of multinucleated cells with osteoclast characteristics in long‐term bone marrow cultures

  1986cited by this paper
• Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors

  1986cited by this paper
• Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity.

  1985cited by this paper
• Interleukin abnormalities in recently active rheumatoid arthritis.

  1984cited by this paper
• An interleukin 1 like factor stimulates bone resorption in vitro

  1983cited by this paper

• Evaluation of the periodontal status in menopause women’s visiting dental hospital: An observational study

  2026cites this paper
• Ashwagandha and Shatavari Extracts Dose-Dependently Reduce Menopause Symptoms, Vascular Dysfunction, and Bone Resorption in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Study

  2025cites this paper
• Immediate Implant Placement in the Esthetic Zone: A Multi-Variate Analysis of Influencing Factors.

  2025cites this paper
• Ovarian Aging: The Silent Catalyst of Age-Related Disorders in Female Body

  2025cites this paper
• The role of probiotics in modulating RANKL in osteoporosis: A systematic review of animal interventional studies and RCTs.

  2025cites this paper
• Interconnected Pathways of Alzheimer's Disease and Osteoporosis: A Review of Genetic, Hormonal, and Environmental Influences

  2025cites this paper
• Postmenopausal osteoporosis increases periodontal inflammation and the pathogenicity of the oral microbiota in a rat model

  2025cites this paper
• Effect of Thyroid-Stimulating Hormone Suppression on Bone Mineral Density in Patients with Differentiated Thyroid Carcinoma: A Single Center Retrospective Study

  2025cites this paper
• Does exercising during peri- or early post-menopause prevent bone and muscle loss: A systematic review.

  2025cites this paper
• Associations between serum cytokine levels and postmenopausal depression in postmenopausal women with and without menopause hormone therapy

  2025cites this paper
• Citrate: a key signalling molecule and therapeutic target for bone remodeling disorder

  2025cites this paper
• Analysis and validation of biomarkers of immune cell-related genes in postmenopausal osteoporosis: An observational study

  2024cites this paper
• A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer

  2024cites this paper
• Changes in blood physiological and biochemical parameters and intestinal flora in newborn horses and mares with angular limb deformities

  2024cites this paper
• Association of neutrophil to lymphocyte ratio with bone mineral density in post-menopausal women: a systematic review and meta-analysis

  2024cites this paper
• Differential Regulatory Effects of Probiotics on Bone Metabolism by the Status of Bone Health and Delivery Route

  2024cites this paper
• Olink Proteomics for the Identification of Biomarkers for Early Diagnosis of Postmenopausal Osteoporosis

  2024cites this paper
• Navigating Post-Traumatic Osteoporosis: A Comprehensive Review of Epidemiology, Pathophysiology, Diagnosis, Treatment, and Future Directions

  2024cites this paper
• Probiotics enhance alveolar bone microarchitecture, intestinal morphology and estradiol levels in osteoporotic animals.

  2024cites this paper
• Exploring the Role of Hormones and Cytokines in Osteoporosis Development

  2024cites this paper
• LPL-RH suppresses bone loss in ovariectomised rat models

  2024cites this paper
• Diagnostic biomarkers for periodontitis (observational case-control study)

  2024cites this paper
• Osteoporoz ve Periodontal Hastalıklar Arasındaki İlişki Üzerine Derleme

  2024cites this paper
• Pre-implantation teriparatide administration improves initial implant stability and accelerates the osseointegration process in osteoporotic rats

  2024cites this paper
• New potential selective estrogen receptor modulators in traditional Chinese medicine for treating menopausal syndrome

  2024cites this paper
• Association Between the Dietary Inflammatory Index and the Risk of Fracture in Chinese Adults: Longitudinal Study

  2023cites this paper
• Irisin as an agent for protecting against osteoporosis: A review of the current mechanisms and pathways

  2023cites this paper
• Eicosapentaenoic acid supplementation modulates the osteoblast/osteoclast balance in inflammatory environments and protects against estrogen deficiency-induced bone loss in mice.

  2023cites this paper
• Wnt10b regulates osteogenesis of adipose‐derived stem cells through Wnt/β‐catenin signalling pathway in osteoporosis

  2023cites this paper
• Roles of the Siglec family in bone and bone homeostasis.

  2023cites this paper
• Endocrine, Metabolic, and Immune Pathogenesis of Postmenopausal Osteoporosis. Is there a Therapeutic Role in Natural Products?

  2023cites this paper
• The development, incidence and treatment trends of trochanteric fractures in Germany: a cohort study

  2023cites this paper
• Evaluation of Thyroid Function of HIV Patients in Umunze, Anambra State, Nigeria

  2023cites this paper
• Advances in the research on myokine-driven regulation of bone metabolism

  2023cites this paper
• Associations Between Inflammatory Mediators and Bone Outcomes in Postmenopausal Women: A Cross-Sectional Analysis of Baseline Data from the Prune Study

  2023cites this paper
• Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis

  2023cites this paper
• Prune consumption attenuates pro-inflammatory cytokine secretion and alters monocyte activation in postmenopausal women: secondary outcome analysis of a 12-month randomized controlled trial: The Prune Study.

  2023cites this paper
• IL-1 Mediates Chronic Stress-Induced Hyperalgesia Accompanied by Microglia and Astroglia Morphological Changes in Pain-Related Brain Regions in Mice

  2023cites this paper
• Daytime administration of melatonin has better protective effects on bone loss in ovariectomized rats

  2023cites this paper
• Analyzing Sex-Specific Dimorphism in Human Skeletal Stem Cells

  2023cites this paper
• Circulating IGFBP-3 and Interleukin 6 as Predictors of Osteoporosis in Postmenopausal Women: A Cross-Sectional Study

  2023cites this paper
• Vitamin D receptor gene polymorphisms influence on clinical profile and bone mineral density at different skeletal sites in postmenopausal osteoporotic women

  2023cites this paper
• Exercise for osteoporosis: A literature review of pathology and mechanism

  2022cites this paper
• Etiological factors of facial nerve stimulation in cochlear implant users

  2022cites this paper
• Systemic administration with melatonin in the daytime has a better effect on promoting osseointegration of titanium rods in ovariectomized rats

  2022cites this paper
• Impact of seborrheic dermatitis on osteoporosis risk: A population‐based cohort study

  2022cites this paper
• RETRACTED ARTICLE: High-mobility group box chromosomal protein-1 deletion alleviates osteoporosis in OVX rat model via suppressing the osteoclastogenesis and inflammation

  2022cites this paper
• Osteoporosis and periodontal diseases - An update on their association and mechanistic links.

  2022cites this paper
• Positive relation between dietary inflammatory index and osteoporosis in postmenopausal women.

  2022cites this paper
• Sialylation of TLR2 initiates osteoclast fusion

  2022cites this paper
• The Effects of Er Xian Decoction Combined with Baduanjin Exercise on Bone Mineral Density, Lower Limb Balance Function, and Mental Health in Women with Postmenopausal Osteoporosis: A Randomized Controlled Trial

  2022cites this paper
• Roles of Altered Macrophages and Cytokines: Implications for Pathological Mechanisms of Postmenopausal Osteoporosis, Rheumatoid Arthritis, and Alzheimer’s Disease

  2022cites this paper
• Impacts of Angelica Polysaccharide on Proliferation and Differentiation of Mesenchymal Stem Cells of Rat Bone Marrow

  2022cites this paper
• Anti-Osteoporosis Potencies of Zingiber officinale Rosc. Rhizome Water Extract and DFA III Produced from Dahlia spp. L.: in vivo and in vitro Studies

  2022cites this paper
• The role of metabolites under the influence of genes and lifestyles in bone density changes

  2022cites this paper
• FAEE exerts a protective effect against osteoporosis by regulating the MAPK signalling pathway

  2022cites this paper
• Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: A randomized, double-blind, placebo-controlled trial.

  2022cites this paper
• Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss

  2022cites this paper
• Association of Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin with Secondary Hypogonadism in Egyptian Females with Beta-Thalassemia Major

  2021cites this paper
• Androgens and estrogens predict sexual function after autologous hematopoietic stem cell transplant in men

  2021cites this paper
• Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling Pathways

  2021cites this paper
• Theaflavin-3,3′-Digallate Promotes the Formation of Osteoblasts Under Inflammatory Environment and Increases the Bone Mass of Ovariectomized Mice

  2021cites this paper
• Sex Difference in the Socioeconomic Burden of Osteoporosis among South Koreans

  2021cites this paper
• The Effects of Sex and Estrogen on Radiographic Progression of Ankylosing Spondylitis in Korean Patients

  2021cites this paper
• HIV and Menopause are Independently Associated with Lower Bone Mineral Density: Results from the Women's Interagency HIV Study.

  2021cites this paper
• Prednisolone suppresses collagen-encoding gene expression causing cartilage defects in zebrafish larvae.

  2021cites this paper
• Bone, muscle, and sarcopenia

  2021cites this paper
• Interaction between bone and immune cells: Implications for postmenopausal osteoporosis.

  2021cites this paper
• Sex differences in systemic bone and muscle loss following femur fracture in mice

  2021cites this paper
• MiR-23b-3p promotes postmenopausal osteoporosis by targeting MRC2 and regulating the Wnt/β-catenin signaling pathway.

  2021cites this paper
• Hepcidin contributes to Swedish mutant APP-induced osteoclastogenesis and trabecular bone loss

  2021cites this paper
• Chitosan based bionanocomposites in osteoporosis

  2021cites this paper
• Anti-Siglec-15 antibody suppresses bone resorption by inhibiting osteoclast multinucleation without attenuating bone formation.

  2021cites this paper
• Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis

  2021cites this paper
• Lipoic acid (LA) dose-dependently protects bone losses in the mandible of rats during the development of osteopenia by inhibiting oxidative stress and promoting bone formation.

  2021cites this paper
• Гормональная регуляция остеогенеза

  2021cites this paper
• Primary chronic osteomyelitis of the jaw: Rapid improvement after hormonal suppression in a girl with precocious puberty

  2021cites this paper
• Role of Sex Hormones in Human Body

  2021cites this paper
• The role of estrogens in osteosarcopenia: from biology to potential dual therapeutic effects

  2021cites this paper
• Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice

  2021cites this paper
• CHAPTER 7

  2020cites this paper
• Effect of pre-treatment of strength training and raloxifene in periestropause on bone healing.

  2020cites this paper
• Bone union formation in the rat mandibular symphysis using hydroxyapatite with or without simvastatin: effects on healthy, diabetic, and osteoporotic rats

  2020cites this paper
• Paradigm shift in pathophysiology of vasomotor symptoms: Effects of estradiol withdrawal and progesterone therapy

  2020cites this paper
• CaSR-Mediated hBMSCs Activity Modulation: Additional Coupling Mechanism in Bone Remodeling Compartment

  2020cites this paper
• Evaluation of Salivary and Serum Total Antioxidant Capacity and Lipid Peroxidation in Postmenopausal Women

  2020cites this paper
• Systemic Inflammation: A Risk Factor for Osteoporosis in Pre- and Post-menopausal Women

  2020cites this paper
• Optimising the management of osteoporosis.

  2020cites this paper
• Andrographolide modulates OPG/RANKL axis to promote osteoblastic differentiation in MC3T3-E1 cells and protects bone loss during estrogen deficiency in rats.

  2020cites this paper
• The predictive significance of bone mineral density on postoperative pain relief in knee osteoarthritis patients after total knee arthroplasty: A prediction model.

  2020cites this paper
• Osteotropic cytokines mediate human osteoblast-like cell eicosanoid production

  2020cites this paper
• Oral manifestation and its management in postmenopausal women: an integrated review

  2020cites this paper
• Prevalence of periapical lesions in patients with osteoporosis.

  2020cites this paper
• The Role of Bone Turnover Markers in the Follow up of the Treatment of Osteoporosis

  2020cites this paper
• Managing acute cancer pain.

  2020cites this paper
• Proanthocyanidin-rich grape seed extract improves bone loss, bone healing, and implant osseointegration in ovariectomized animals

  2020cites this paper
• Alterations in osteocyte mediated osteoclastogenesis during estrogen deficiency and under ROCK-II inhibition: An in vitro study using a novel postmenopausal multicellular niche model.

  2020cites this paper
• Predicting Response to Radiotherapy in Cancer-Induced Bone Pain: Cytokines as a Potential Biomarker?

  2020cites this paper
• Type I collagen structure, synthesis, and regulation

  2020cites this paper
• Water Extract of Lysimachia christinae Inhibits Trabecular Bone Loss and Fat Accumulation in Ovariectomized Mice

  2020cites this paper